Irvine MW , Costa BM , Dlaboga D , Culley GR , Hulse R , Scholefield CL , Atlason P , Fang G , Eaves R , Morley R , Mayo-Martin MB , Amici M , Bortolotto ZA , Donaldson L , Collingridge GL , Molnár E , Monaghan DT , Jane DE .

BB/F012519/1 Biotechnology and Biological Sciences Research Council , G0601509 Medical Research Council , G0601812 Medical Research Council , MH60252 NIMH NIH HHS, R01 MH060252-05A2 NIMH NIH HHS, R01 MH060252-06 NIMH NIH HHS, R01 MH060252-07 NIMH NIH HHS, R01 MH060252-08 NIMH NIH HHS, R01 MH060252 NIMH NIH HHS, G0601813 Medical Research Council , MRC_G0601813 Medical Research Council

Alushin, Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists. 2011, Pubmed

Alushin, Binding site and ligand flexibility revealed by high resolution crystal structures of GluK1 competitive antagonists. 2011, Pubmed
Anderson, Capabilities of the WinLTP data acquisition program extending beyond basic LTP experimental functions. 2007, Pubmed
Atlason, Mapping the ligand binding sites of kainate receptors: molecular determinants of subunit-selective binding of the antagonist [3H]UBP310. 2010, Pubmed
Bettler, Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development. 1990, Pubmed , Xenbase
Bortolotto, Kainate receptors are involved in synaptic plasticity. 1999, Pubmed
Bortolotto, Synaptic plasticity in the hippocampal slice preparation. 2011, Pubmed
Buller, Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes. 1997, Pubmed , Xenbase
Buller, The molecular basis of NMDA receptor subtypes: native receptor diversity is predicted by subunit composition. 1994, Pubmed , Xenbase
Cheng, Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. 1973, Pubmed
Clarke, A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission. 1997, Pubmed
Collingridge, A nomenclature for ligand-gated ion channels. 2009, Pubmed
Costa, N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. 2009, Pubmed , Xenbase
Costa, A novel family of negative and positive allosteric modulators of NMDA receptors. 2010, Pubmed , Xenbase
Dolman, Structure-activity relationship studies on N3-substituted willardiine derivatives acting as AMPA or kainate receptor antagonists. 2006, Pubmed
Dolman, Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors. 2005, Pubmed
Dominguez, Two prodrugs of potent and selective GluR5 kainate receptor antagonists actives in three animal models of pain. 2005, Pubmed
Durand, Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. 1992, Pubmed , Xenbase
Durocher, High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. 2002, Pubmed
Evans, A comparison of excitatory amino acid antagonists acting at primary afferent C fibres and motoneurones of the isolated spinal cord of the rat. 1987, Pubmed
Feng, Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. 2004, Pubmed , Xenbase
Filla, Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine. 2002, Pubmed
Fischer, Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. 1997, Pubmed , Xenbase
Hargreaves, A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. 1988, Pubmed
Hizue, Involvement of N-methyl-D-aspartate-type glutamate receptor epsilon1 and epsilon4 subunits in tonic inflammatory pain and neuropathic pain. 2005, Pubmed
Hoo, Functional expression and pharmacological characterization of the human EAA4 (GluR6) glutamate receptor: a kainate selective channel subunit. 1994, Pubmed
Hulse, Characterization of a novel neuropathic pain model in mice. 2008, Pubmed
Jane, Kainate receptors: pharmacology, function and therapeutic potential. 2009, Pubmed
Kalia, NMDA receptors in clinical neurology: excitatory times ahead. 2008, Pubmed
Kerchner, Kainate receptor subunits underlying presynaptic regulation of transmitter release in the dorsal horn. 2002, Pubmed
Kew, Ionotropic and metabotropic glutamate receptor structure and pharmacology. 2005, Pubmed
Kinarsky, Identification of subunit- and antagonist-specific amino acid residues in the N-Methyl-D-aspartate receptor glutamate-binding pocket. 2005, Pubmed , Xenbase
Klapars, Copper-catalyzed halogen exchange in aryl halides: an aromatic Finkelstein reaction. 2002, Pubmed
Korczak, cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. 1995, Pubmed
Lucifora, Presynaptic low- and high-affinity kainate receptors in nociceptive spinal afferents. 2006, Pubmed
Mayer, Crystal structures of the kainate receptor GluR5 ligand binding core dimer with novel GluR5-selective antagonists. 2006, Pubmed , Xenbase
Molnár, Biochemical and immunocytochemical characterization of antipeptide antibodies to a cloned GluR1 glutamate receptor subunit: cellular and subcellular distribution in the rat forebrain. 1993, Pubmed
More, Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist. 2004, Pubmed
Morley, Synthesis and pharmacology of N1-substituted piperazine-2,3-dicarboxylic acid derivatives acting as NMDA receptor antagonists. 2005, Pubmed , Xenbase
Mosley, Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective N-methyl-D-aspartate receptor antagonists. 2010, Pubmed , Xenbase
Neyton, Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach. 2006, Pubmed
Nutt, Molecular characterization of the human EAA5 (GluR7) receptor: a high-affinity kainate receptor with novel potential RNA editing sites. 1994, Pubmed
O'Neill, LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia. 2000, Pubmed
O'Neill, Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia. 1998, Pubmed
Perrais, Antagonism of recombinant and native GluK3-containing kainate receptors. 2009, Pubmed
Pook, A comparison of the actions of agonists and antagonists at non-NMDA receptors of C fibres and motoneurones of the immature rat spinal cord in vitro. 1993, Pubmed
Sanacora, Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. 2008, Pubmed
SCHULTZ, Attempts to find new antimalarials; derivatives of phenanthrene; amino alcohols derived from 9-chlorophenanthrene. 1946, Pubmed
Sheardown, 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. 1990, Pubmed
Simmons, Kainate GluR5 receptor subtype mediates the nociceptive response to formalin in the rat. 1998, Pubmed
Smolders, Antagonists of GLU(K5)-containing kainate receptors prevent pilocarpine-induced limbic seizures. 2002, Pubmed
Summers, Hydroxamic acid inhibitors of 5-lipoxygenase. 1987, Pubmed
Traynelis, Glutamate receptor ion channels: structure, regulation, and function. 2010, Pubmed
Vignes, The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus. 1998, Pubmed
Watkins, The glutamate story. 2006, Pubmed
Weiss, Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivo. 2006, Pubmed
Wendt, Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution. 2004, Pubmed
Wilding, Functional diversity and developmental changes in rat neuronal kainate receptors. 2001, Pubmed